BIOMAX PRESENTS NEUROIMAGING SOLUTION NICARA™ AT ALZHEIMER CONFERENCE

Wondering about the prognosis of your Alzheimer's patient or why some of them respond positively to your treatment? Some of the answers may lay in the Connectome!

Biomax presents NICARA™, a novel, unique and cost-effective neuroimaging solution focusing on Connectomics at the current virtual AAIC Alzheimer's Association International Conference. Register today for free and learn how NICARA can help you.

NICARA stands for NeuroImaging-based Connectome Assessment in Research and Application. The innovative software is especially designed for people working with brain data, who wish to gain a deeper insight into the world of Connectomics. Using one or more modules of NICARA™, users can easily build, browse, edit or compare connectomes, without extensive prior knowledge in this field. 

Four different modules are currently available. Further modules are coming soon. As zero-footprint solution no software or hardware installations are required on customers site.

Visitors to the AAIC 2020 will have the opportunity to visit Biomax's virtual booth to get more information about NICARA™, request a live demo and talk to the experts via chat.

BIOMAX CONTRIBUTES TO RESEARCH RESPONSE ON COVID-19

Searching for drugs to repurpose for COVID-19 or trying to avoid the pitfalls that led to the failure of the SARS vaccines? The public AILAIN COVID-19 scientific assistant may provide some of the answers!

Biomax contributes to the research response on COVID-19/SARS-CoV-2 in multiple ways. As partner in the EU-project PREPARE (Platform for European Preparedness Against (Re-)emerging Epidemics) and member of the COVID-19 Disease Map Collaboration we apply literature mining and knowledge integration and make the results publicly available with our scientific assistant AILANI for COVID-19 research. Together with Sagacious Research we now extend this information to include patents.

In collaboration with several Bavarian partners we support SARS-CoV-2 vaccine research. Finally, in collaboration with our partner CIRO+ we apply our System Medicine implementation of the BioXM Knowledge Management and our Viscovery AI-based machine learning to research persistent symptoms in COVID-19 patients.

AILANI FOR COVID-19

Mid of May 2020 Biomax made its semantic search platform AILANI available free of charge to research institutes around the world in order to support the rapid and successful search for drugs and suitable vaccines against COVID-19 infections.

Pre-configured for the specific needs in the field of COVID-19 scientists get faster insight in existing knowledge, discover previously unknown associations and are able to take better research decisions. AILANI for COVID-19 is accessible at https://ailani.ai. 

AILANI FOR PHARMA, AGROTECH & FOOD

In the first half of 2020 Biomax held a series of online seminars and live demos on AILANI for the pharmaceutical and biotech, agrotech and food sectors.

In each seminar, the search engine was presented and the possibilities of AILANI and the advantages for customers from industry, research and science were highlighted using industry-specific case studies.

The recordings of all sessions can be viewed again via Biomax's YouTube channel.